Activist investor Bluebell takes stake in GSK
Activist Bluebell takes stake in GlaxoSmithKline to push for change at top
GlaxoSmithKline Talks Up Growth Prospects as Activist Investor Elliott Looms - WSJ
Meet Bluebell Capital Partners, Activist Investor Taking on BlackRock
After bruising year, GSK approaches consumer split in better health
GSK Beats Expectations, Shingles Vaccine Bolsters Outlook
Shares Magazine 21 April 2022 by Shares Magazine - Issuu
Second hedge fund applies pressure on GSK after taking stake
After bruising year, GSK approaches consumer split in better health
Activist investor Bluebell is latest to call for 'sleeping' GSK's CEO to quit, 2021-09-23
An Autumn of Activism Awaits European Luxury, Consumer Giants – WWD